Freezing effects on the acute myeloid leukemia cell proteome and phosphoproteome revealed using optimal quantitative workflows

Journal of Proteomics

Volumn 145, Issue , 2016, Pages 214-225

  Aasebø, Elise ^a   Mjaavatten, Olav ^a   Vaudel, Marc ^a   Farag, Yehia ^a   Selheim, Frode ^a   Berven, Frode ^a   Bruserud, Øystein ^a   Hernandez Valladares, Maria ^a  

^a UNIVERSITY OF BERGEN   (Norway)

Author keywords

Acute myeloid leukemia; Biomarkers; Phosphoproteomics; Proteomics

Indexed keywords

AMINO ACID; ANION TRANSPORT PROTEIN; CARBONATE DEHYDRATASE I; HEMOGLOBIN GAMMA CHAIN; LIQUID NITROGEN; MITOCHONDRIAL PROTEIN; NUCLEIC ACID BINDING PROTEIN; OXIDOREDUCTASE; PEROXIREDOXIN 2; PHOSPHATASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 5 PHOSPHATASE 1; PHOSPHOPEPTIDE; PROTEOME; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); THIOREDOXIN; THROMBIN; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; TUMOR MARKER;

ACUTE MYELOBLASTIC LEUKEMIA; AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; CELL FRACTIONATION; CELL ISOLATION; CELL SELECTION; CELL SURFACE; CRYOPRESERVATION; ELECTRON TRANSPORT; HUMAN; HUMAN CELL; ISOTOPE LABELING; PHOSPHOPROTEOMICS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RESPIRATORY CHAIN; RNA SPLICING; SIGNAL TRANSDUCTION; UBIQUITINATION; ACUTE MYELOID LEUKEMIA; FREEZING; METABOLISM; PATHOLOGY; PHOSPHORYLATION; WORKFLOW;

APOPTOSIS REGULATORY PROTEINS; BIOMARKERS, TUMOR; ELECTRON TRANSPORT; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FREEZING; HUMANS; ISOTOPE LABELING; LEUKEMIA, MYELOID, ACUTE; PHOSPHOPEPTIDES; PHOSPHORYLATION; PROTEOME; THROMBIN; WORKFLOW;

EID: 84990946552     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2016.03.049     Document Type: Article

References (79)

1. [1] Vardiman, J.W., Thiele, J., Arber, D.A., Brunning, R.D., Borowitz, M.J., Porwit, A., et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 114 (2009), 937–951.
2. [2] Grimwade, D., Hills, R.K., Moorman, A.V., Walker, H., Chatters, S., Goldstone, A.H., et al. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. Blood 116 (2010), 354–365.
3. [3] Grimwade, D., Walker, H., Oliver, F., Wheatley, K., Harrison, C., Harrison, G., et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 92 (1998), 2322–2333.
4. [4] Tallman, M.S., Altman, J.K., How I treat acute promyelocytic leukemia. Blood 114 (2009), 5126–5135.
5. [5] Aasebo, E., Forthun, R.B., Berven, F., Selheim, F., Hernandez-Valladares, M., Global cell proteome profiling, phospho-signaling and quantitative proteomics for identification of new biomarkers in acute myeloid leukemia patients. Curr. Pharm. Biotechnol. 17 (2016), 52–70.
6. [6] Casado, P., Rodriguez-Prados, J.C., Cosulich, S.C., Guichard, S., Vanhaesebroeck, B., Joel, S., et al. Kinase-substrate enrichment analysis provides insights into the heterogeneity of signaling pathway activation in leukemia cells. Sci. Signal., 6, 2013, rs6.
7. [7] Irish, J.M., Hovland, R., Krutzik, P.O., Perez, O.D., Bruserud, O., Gjertsen, B.T., et al. Single cell profiling of potentiated phospho-protein networks in cancer cells. Cell 118 (2004), 217–228.
8. [8] Cattaneo, F., Guerra, G., Parisi, M., De Marinis, M., Tafuri, D., Cinelli, M., et al. Cell-surface receptors transactivation mediated by g protein-coupled receptors. Int. J. Mol. Sci. 15 (2014), 19700–19728.
9. [9] Bruserud, O., Nepstad, I., Hauge, M., Hatfield, K.J., Reikvam, H., STAT3 as a possible therapeutic target in human malignancies: lessons from acute myeloid leukemia. Expert. Rev. Hematol. 8 (2015), 29–41.
10. [10] Anastas, J.N., Functional crosstalk between WNT signaling and tyrosine kinase signaling in cancer. Semin. Oncol. 42 (2015), 820–831.
11. [11] Schaab, C., Oppermann, F.S., Klammer, M., Pfeifer, H., Tebbe, A., Oellerich, T., et al. Global phosphoproteome analysis of human bone marrow reveals predictive phosphorylation markers for the treatment of acute myeloid leukemia with quizartinib. Leukemia 28 (2014), 716–719.
12. [12] Oellerich, T., Mohr, S., Corso, J., Beck, J., Dobele, C., Braun, H., et al. FLT3-ITD and TLR9 use Bruton tyrosine kinase to activate distinct transcriptional programs mediating AML cell survival and proliferation. Blood 125 (2015), 1936–1947.
13. [13] Zhang, L., Freitas, M.A., Wickham, J., Parthun, M.R., Klisovic, M.I., Marcucci, G., et al. Differential expression of histone post-translational modifications in acute myeloid and chronic lymphocytic leukemia determined by high-pressure liquid chromatography and mass spectrometry. J. Am. Soc. Mass Spectrom. 15 (2004), 77–86.
14. [14] Dickhut, C., Radau, S., Zahedi, R.P., Fast, efficient, and quality-controlled phosphopeptide enrichment from minute sample amounts using titanium dioxide. Methods Mol. Biol. 1156 (2014), 417–430.
15. [15] Thingholm, T.E., Jorgensen, T.J., Jensen, O.N., Larsen, M.R., Highly selective enrichment of phosphorylated peptides using titanium dioxide. Nat. Protoc. 1 (2006), 1929–1935.
16. [16] Thingholm, T.E., Larsen, M.R., The use of titanium dioxide for selective enrichment of phosphorylated peptides. Methods Mol. Biol. 1355 (2016), 135–146.
17. [17] Thingholm, T.E., Larsen, M.R., Phosphopeptide enrichment by immobilized metal affinity chromatography. Methods Mol. Biol. 1355 (2016), 123–133.
18. [18] Thingholm, T.E., Jensen, O.N., Robinson, P.J., Larsen, M.R., SIMAC (sequential elution from IMAC), a phosphoproteomics strategy for the rapid separation of monophosphorylated from multiply phosphorylated peptides. Mol. Cell. Proteomics 7 (2008), 661–671.
19. [19] Thingholm, T.E., Larsen, M.R., Sequential elution from IMAC (SIMAC): an efficient method for enrichment and separation of mono- and multi-phosphorylated peptides. Methods Mol. Biol. 1355 (2016), 147–160.
20. [20] Bruserud, O., Gjertsen, B.T., Foss, B., Huang, T.S., New strategies in the treatment of acute myelogenous leukemia (AML): in vitro culture of aml cells—the present use in experimental studies and the possible importance for future therapeutic approaches. Stem Cells 19 (2001), 1–11.
21. [21] Bruserud, O., Hovland, R., Wergeland, L., Huang, T.S., Gjertsen, B.T., Flt3-mediated signaling in human acute myelogenous leukemia (AML) blasts: a functional characterization of Flt3-ligand effects in AML cell populations with and without genetic Flt3 abnormalities. Haematologica 88 (2003), 416–428.
22. [22] Hatfield, K.J., Hovland, R., Oyan, A.M., Kalland, K.H., Ryningen, A., Gjertsen, B.T., et al. Release of angiopoietin-1 by primary human acute myelogenous leukemia cells is associated with mutations of nucleophosmin, increased by bone marrow stromal cells and possibly antagonized by high systemic angiopoietin-2 levels. Leukemia 22 (2008), 287–293.
23. [23] Aasebo, E., Vaudel, M., Mjaavatten, O., Gausdal, G., Van der Burgh, A., Gjertsen, B.T., et al. Performance of super-SILAC based quantitative proteomics for comparison of different acute myeloid leukemia (AML) cell lines. Proteomics 14 (2014), 1971–1976.
24. [24] Geiger, T., Cox, J., Ostasiewicz, P., Wisniewski, J.R., Mann, M., Super-SILAC mix for quantitative proteomics of human tumor tissue. Nat. Methods 7 (2010), 383–385.
25. [25] Kulak, N.A., Pichler, G., Paron, I., Nagaraj, N., Mann, M., Minimal, encapsulated proteomic-sample processing applied to copy-number estimation in eukaryotic cells. Nat. Methods 11 (2014), 319–324.
26. [26] Kelstrup, C.D., Jersie-Christensen, R.R., Batth, T.S., Arrey, T.N., Kuehn, A., Kellmann, M., et al. Rapid and deep proteomes by faster sequencing on a benchtop quadrupole ultra-high-field Orbitrap mass spectrometer. J. Proteome Res. 13 (2014), 6187–6195.
27. [27] Wisniewski, J.R., Zougman, A., Nagaraj, N., Mann, M., Universal sample preparation method for proteome analysis. Nat. Methods 6 (2009), 359–362.
28. [28] Wisniewski, J.R., Rakus, D., Multi-enzyme digestion FASP and the ‘Total Protein Approach’-based absolute quantification of the Escherichia coli proteome. J. Proteome 109 (2014), 322–331.
29. [29] Cox, J., Mann, M., MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26 (2008), 1367–1372.
30. [30] Cox, J., Matic, I., Hilger, M., Nagaraj, N., Selbach, M., Olsen, J.V., et al. A practical guide to the MaxQuant computational platform for SILAC-based quantitative proteomics. Nat. Protoc. 4 (2009), 698–705.
31. [31] Cox, J., Neuhauser, N., Michalski, A., Scheltema, R.A., Olsen, J.V., Mann, M., Andromeda: a peptide search engine integrated into the MaxQuant environment. J. Proteome Res. 10 (2011), 1794–1805.
32. [32] Olsen, J.V., Blagoev, B., Gnad, F., Macek, B., Kumar, C., Mortensen, P., et al. Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 127 (2006), 635–648.
33. [33] de Graaf, E.L., Giansanti, P., Altelaar, A.F., Heck, A.J., Single-step enrichment by Ti4 + -IMAC and label-free quantitation enables in-depth monitoring of phosphorylation dynamics with high reproducibility and temporal resolution. Mol. Cell. Proteomics 13 (2014), 2426–2434.
34. [34] Vizcaino, J.A., Deutsch, E.W., Wang, R., Csordas, A., Reisinger, F., Rios, D., et al. ProteomeXchange provides globally coordinated proteomics data submission and dissemination. Nat. Biotechnol. 32 (2014), 223–226.
35. [35] Vizcaino, J.A., Csordas, A., Del-Toro, N., Dianes, J.A., Griss, J., Lavidas, I., et al. 2016 update of the PRIDE database and its related tools. Nucleic Acids Res. 44 (2016), D447–D456.
36. [36] Arntzen, M.O., Koehler, C.J., Barsnes, H., Berven, F.S., Treumann, A., Thiede, B., IsobariQ: software for isobaric quantitative proteomics using IPTL, iTRAQ, and TMT. J. Proteome Res. 10 (2011), 913–920.
37. [37] Hulsen, T., de Vlieg, J., Alkema, W., BioVenn — a web application for the comparison and visualization of biological lists using area-proportional Venn diagrams. BMC Genomics, 9, 2008, 488.
38. [38] Farag, Y., Berven, F.S., Jonassen, I., Petersen, K., Barsnes, H., Distributed and interactive visual analysis of omics data. J. Proteome 129 (2015), 78–82.
39. [39] Pathan, M., Keerthikumar, S., Ang, C.S., Gangoda, L., Quek, C.Y., Williamson, N.A., et al. FunRich: an open access standalone functional enrichment and interaction network analysis tool. Proteomics 15 (2015), 2597–2601.
40. [40] Mi, H., Poudel, S., Muruganujan, A., Casagrande, J.T., Thomas, P.D., PANTHER version 10: expanded protein families and functions, and analysis tools. Nucleic Acids Res. 44 (2016), D336–D342.
41. [41] Croft, D., Mundo, A.F., Haw, R., Milacic, M., Weiser, J., Wu, G., et al. The Reactome pathway knowledgebase. Nucleic Acids Res. 42 (2014), D472–D477.
42. [42] Crooks, G.E., Hon, G., Chandonia, J.M., Brenner, S.E., WebLogo: a sequence logo generator. Genome Res. 14 (2004), 1188–1190.
43. [43] Colaert, N., Helsens, K., Martens, L., Vandekerckhove, J., Gevaert, K., Improved visualization of protein consensus sequences by iceLogo. Nat. Methods 6 (2009), 786–787.
44. [44] Munk, S., Refsgaard, J.C., Olsen, J.V., Jensen, L.J., From phosphosites to kinases. Methods Mol. Biol. 1355 (2016), 307–321.
45. [45] Munk, S., Refsgaard, J.C., Olsen, J.V., Systems analysis for interpretation of phosphoproteomics data. Methods Mol. Biol. 1355 (2016), 341–360.
46. [46] Szklarczyk, D., Franceschini, A., Wyder, S., Forslund, K., Heller, D., Huerta-Cepas, J., et al. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 43 (2015), D447–D452.
47. [47] Horn, H., Schoof, E.M., Kim, J., Robin, X., Miller, M.L., Diella, F., et al. KinomeXplorer: an integrated platform for kinome biology studies. Nat. Methods 11 (2014), 603–604.
48. [48] Vandermarliere, E., Mueller, M., Martens, L., Getting intimate with trypsin, the leading protease in proteomics. Mass Spectrom. Rev. 32 (2013), 453–465.
49. [49] Luo, M., Reyna, S., Wang, L., Yi, Z., Carroll, C., Dong, L.Q., et al. Identification of insulin receptor substrate 1 serine/threonine phosphorylation sites using mass spectrometry analysis: regulatory role of serine 1223. Endocrinology 146 (2005), 4410–4416.
50. [50] Di Terlizzi, S., Zino, E., Mazzi, B., Magnani, C., Tresoldi, C., Perna, S.K., et al. Therapeutic and diagnostic applications of minor histocompatibility antigen HA-1 and HA-2 disparities in allogeneic hematopoietic stem cell transplantation: a survey of different populations. Biol. Blood Marrow Transplant. 12 (2006), 95–101.
51. [51] Maragozidis, P., Karangeli, M., Labrou, M., Dimoulou, G., Papaspyrou, K., Salataj, E., et al. Alterations of deadenylase expression in acute leukemias: evidence for poly(a)-specific ribonuclease as a potential biomarker. Acta Haematol. 128 (2012), 39–46.
52. [52] Laszlo, G.S., Alonzo, T.A., Gudgeon, C.J., Harrington, K.H., Kentsis, A., Gerbing, R.B., et al. High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group. J. Hematol. Oncol., 8, 2015, 115.
53. [53] Cante-Barrett, K., Pieters, R., Meijerink, J.P., Myocyte enhancer factor 2C in hematopoiesis and leukemia. Oncogene 33 (2014), 403–410.
54. [54] Haaland, I., Opsahl, J.A., Berven, F.S., Reikvam, H., Fredly, H.K., Haugse, R., et al. Molecular mechanisms of nutlin-3 involve acetylation of p53, histones and heat shock proteins in acute myeloid leukemia. Mol. Cancer, 13, 2014, 116.
55. [55] Yang, L., Cao, L., Yang, M., Tang, D., Kang, R., Min, X., et al. Hsp27: a novel therapeutic target for pediatric M4/M5 acute myeloid leukemia. Oncol. Rep. 29 (2013), 1459–1466.
56. [56] Theocharides, A.P., Dobson, S.M., Laurenti, E., Notta, F., Voisin, V., Cheng, P.Y., et al. Dominant-negative Ikaros cooperates with BCR-ABL1 to induce human acute myeloid leukemia in xenografts. Leukemia 29 (2015), 177–187.
57. [57] Court, E.L., Smith, M.A., Avent, N.D., Hancock, J.T., Morgan, L.M., Gray, A.G., et al. DNA microarray screening of differential gene expression in bone marrow samples from AML, non-AML patients and AML cell lines. Leuk. Res. 28 (2004), 743–753.
58. [58] Lu, F., Zhang, J., Ji, M., Li, P., Du, Y., Wang, H., et al. miR-181b increases drug sensitivity in acute myeloid leukemia via targeting HMGB1 and Mcl-1. Int. J. Oncol. 45 (2014), 383–392.
59. [59] Glatter, T., Ludwig, C., Ahrne, E., Aebersold, R., Heck, A.J., Schmidt, A., Large-scale quantitative assessment of different in-solution protein digestion protocols reveals superior cleavage efficiency of tandem Lys-C/trypsin proteolysis over trypsin digestion. J. Proteome Res. 11 (2012), 5145–5156.
60. [60] Lawless, C., Hubbard, S.J., Prediction of missed proteolytic cleavages for the selection of surrogate peptides for quantitative proteomics. OMICS 16 (2012), 449–456.
61. [61] Glatter, T., Ahrne, E., Schmidt, A., Comparison of different sample preparation protocols reveals lysis buffer-specific extraction biases in gram-negative bacteria and human cells. J. Proteome Res. 14 (2015), 4472–4485.
62. [62] Wisniewski, J.R., Mann, M., Consecutive proteolytic digestion in an enzyme reactor increases depth of proteomic and phosphoproteomic analysis. Anal. Chem. 84 (2012), 2631–2637.
63. [63] Fila, J., Honys, D., Enrichment techniques employed in phosphoproteomics. Amino Acids 43 (2012), 1025–1047.
64. [64] Ryningen, A., Ersvaer, E., Oyan, A.M., Kalland, K.H., Vintermyr, O.K., Gjertsen, B.T., et al. Stress-induced in vitro apoptosis of native human acute myelogenous leukemia (AML) cells shows a wide variation between patients and is associated with low BCL-2:Bax ratio and low levels of heat shock protein 70 and 90. Leuk. Res. 30 (2006), 1531–1540.
65. [65] Sasnoor, L.M., Kale, V.P., Limaye, L.S., Supplementation of conventional freezing medium with a combination of catalase and trehalose results in better protection of surface molecules and functionality of hematopoietic cells. J. Hematother. Stem Cell Res. 12 (2003), 553–564.
66. [66] Di Giuseppe, F., Pierdomenico, L., Eleuterio, E., Sulpizio, M., Lanuti, P., Riviello, A., et al. Cryopreservation effects on Wharton's jelly stem cells proteome. Stem Cell Rev. 10 (2014), 429–446.
67. [67] He, Y., Wang, K., Zhao, X., Zhang, Y., Ma, Y., Hu, J., Differential proteome association study of freeze-thaw damage in ram sperm. Cryobiology 72 (2016), 60–68.
68. [68] Martin, G., Cagnon, N., Sabido, O., Sion, B., Grizard, G., Durand, P., et al. Kinetics of occurrence of some features of apoptosis during the cryopreservation process of bovine spermatozoa. Hum. Reprod. 22 (2007), 380–388.
69. [69] Kavanaugh, G., Zhao, R., Guo, Y., Mohni, K.N., Glick, G., Lacy, M.E., et al. Enhancer of rudimentary homolog affects the replication stress response through regulation of RNA processing. Mol. Cell. Biol. 35 (2015), 2979–2990.
70. [70] Skinner, M.M., Trempy, J.E., Expression of clpX, an ATPase subunit of the Clp protease, is heat and cold shock inducible in Lactococcus lactis. J. Dairy Sci. 84 (2001), 1783–1785.
71. [71] Stephenne, X., Najimi, M., Ngoc, D.K., Smets, F., Hue, L., Guigas, B., et al. Cryopreservation of human hepatocytes alters the mitochondrial respiratory chain complex 1. Cell Transplant. 16 (2007), 409–419.
72. [72] Cui, J.W., Wang, J., He, K., Jin, B.F., Wang, H.X., Li, W., et al. Proteomic analysis of human acute leukemia cells: insight into their classification. Clin. Cancer Res. 10 (2004), 6887–6896.
73. [73] Braoudaki, M., Tzortzatou-Stathopoulou, F., Anagnostopoulos, A.K., Papathanassiou, C., Vougas, K., Karamolegou, K., et al. Proteomic analysis of childhood de novo acute myeloid leukemia and myelodysplastic syndrome/AML: correlation to molecular and cytogenetic analyses. Amino Acids 40 (2011), 943–951.
74. [74] Lopez-Pedrera, C., Villalba, J.M., Siendones, E., Barbarroja, N., Gomez-Diaz, C., Rodriguez-Ariza, A., et al. Proteomic analysis of acute myeloid leukemia: identification of potential early biomarkers and therapeutic targets. Proteomics 6:Suppl. 1 (2006), S293–S299.
75. [75] Luczak, M., Kazmierczak, M., Handschuh, L., Lewandowski, K., Komarnicki, M., Figlerowicz, M., Comparative proteome analysis of acute myeloid leukemia with and without maturation. J. Proteome 75 (2012), 5734–5748.
76. [76] Bai, J., He, A., Zhang, W., Huang, C., Yang, J., Yang, Y., et al. Potential biomarkers for adult acute myeloid leukemia minimal residual disease assessment searched by serum peptidome profiling. Proteome Sci., 11, 2013, 39.
77. [77] Fujiwara, Y., Denlinger, D.L., p38 MAPK is a likely component of the signal transduction pathway triggering rapid cold hardening in the flesh fly Sarcophaga crassipalpis. J. Exp. Biol. 210 (2007), 3295–3300.
78. [78] Iwata, K., Shindome, C., Kobayashi, Y., Takeda, M., Yamashita, O., Shiomi, K., et al. Temperature-dependent activation of ERK/MAPK in yolk cells and its role in embryonic diapause termination in the silkworm Bombyx mori. J. Insect Physiol. 51 (2005), 1306–1312.
79. [79] Reikvam, H., Hoang, T.T., Bruserud, O., Emerging therapeutic targets in human acute myeloid leukemia (part 2) — bromodomain inhibition should be considered as a possible strategy for various patient subsets. Expert. Rev. Hematol. 8 (2015), 315–327.